ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NRSAs Renamed For Kirschstein.

June 21, 2002

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

Four RFAs Released For RM Program

November 6, 1981